Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 18.11MTotal Liabilities
VS
Market
Sector
Industry
History
$ 2.3Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information
Ticker
SABSCompany Name
SAB BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAB BIOTHERAPEUTICS INC - Total Liabilities Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SABS - Liabilities Historical data
| Date | Total Liabilities |
|---|---|
| 6/30/2025 | $ 18.11M |
| 3/31/2025 | $ 16.71M |
| 12/31/2024 | $ 18.23M |
| 9/30/2024 | $ 16.89M |
| 6/30/2024 | $ 15.77M |
| 3/31/2024 | $ 18.55M |
| 12/31/2023 | $ 26.64M |
| 9/30/2023 | $ 13.08M |
| 6/30/2023 | $ 15.73M |
| 3/31/2023 | $ 18.27M |
Key Performance Insights, Last 5 Years
- SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Liabilities stands at $ 55.56K.
- Over the past 5 years, SAB BIOTHERAPEUTICS INC's average Liabilities has been $ 18.94M.
- The median Liabilities for SAB BIOTHERAPEUTICS INC during this period was $ 18.17M
- SAB BIOTHERAPEUTICS INC reached its highest Liabilities over the past 5 years at $ 40.82M.
- The lowest Liabilities recorded by SAB BIOTHERAPEUTICS INC in the same timeframe $ 55.56K
SAB BIOTHERAPEUTICS INC's Liabilities vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities Benchmarks
Similar metrics to Liabilities:
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Free Cash Flow to Debt - [Calculation] The Free Cash Flow to Debt ratio allows investors to judge a company’s financial stability. It represents the fraction of debt that could be repaid within one year if all of the free cash flow would be used to repay debt. It is calculated by dividing Free Cash Flow [FCF] by a company’s [Liabilities].
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Debt to Equity Ratio - [Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
Definition of Total Liabilities
[Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.SABS - Total Liabilities, Last 5 years
$ 55.56K
Minimum
Dec 31, 2020
$ 40.82M
Maximum
Dec 31, 2021
$ 18.94M
Average
$ 18.17M
Median
Liabilities Benchmark AnalysisMarket
The chart above depicts the distribution of Liabilities for companies in the Total Stock Market. The average Liabilities of the companies is $ 614.93M with a standard deviation of $ 856.34M.
The following table provides additional summary stats:
Liabilities in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ 0 |
| max | $ 3.48B |
| average | $ 614.93M |
| median | $ 180.48M |
| std | $ 856.34M |